Key Takeaways
- ECB Governing Council member Emmanuel Moulin warns that the Eurozone is facing a significant inflationary shock driven 100% by energy costs, though second-round effects remain absent.
- Goldman Sachs reports that one-third of China’s Q2 petrochemical oil demand weakness was reversed by August, suggesting that structural demand destruction may be overstated.
- Equinor (EQNR) announced a new gas discovery in the Gullfaks licence area, with recoverable volumes estimated between 0.5 million and 1.6 million standard cubic metres of oil equivalent.
- South Korea’s KOSPI index plummeted 2.6% to close at 6,625.93, driven by heavy selling from foreign and institutional investors amid rising global treasury yields.
- Bayer (BAYRY) received U.S. FDA acceptance for its Kerendia filing, seeking to expand treatment for chronic kidney disease (CKD) to patients without diabetes.
Central Banks Navigate Inflation and Growth Risks
The European Central Bank (ECB) is currently grappling with a concentrated inflationary shock. ECB official Emmanuel Moulin noted that while energy prices are the sole driver of current inflation spikes in the Euro area, the cumulative effect of higher interest rates is now visibly affecting all member countries. Despite these pressures, the central bank has not yet observed "second-round effects," such as wage-price spirals, which may provide some flexibility in future policy pathing.
In Japan, the Bank of Japan (BOJ) reported that financial conditions in the Osaka region remain loose, though officials are closely monitoring the impact of recent rate hikes on corporate funding. The BOJ highlighted a divergence in the economy: a weak Yen continues to support large exporters and major firms in Osaka, while smaller service-sector companies remain increasingly exposed to the currency's downside. Meanwhile, Prime Minister Sanae Takaichi indicated that the government would consider extending tax cuts flexibly in the event of economic emergencies.
Energy Markets: China Demand and New Discoveries
Goldman Sachs (GS) analysts have released a series of notes tempering concerns over a permanent slump in Chinese oil demand. The bank noted that nearly one-third of the weakness seen in China’s petrochemical oil demand during Q2 was reversed by August. While gasoline and diesel demand remain depressed due to high domestic product prices, Goldman suggests that "feedstock switching" is contributing only modestly to the current weakness, and the overall downturn in petrochemical demand is unlikely to persist.
On the supply side, Equinor (EQNR and its partners Petoro and OMV have confirmed a discovery at the Gullfaks South field in the North Sea. The discovery, located approximately 190 kilometers northwest of Bergen, is expected to yield between 3.3 million and 10.3 million barrels of oil equivalent. This find is seen as a "profitable barrel" that can be quickly tied into existing infrastructure to maintain production levels at the mature Gullfaks hub.
Corporate and Regional Market Developments
Bayer (BAYRY) continues to expand its pharmaceutical portfolio as the U.S. FDA accepted its supplemental New Drug Application for Kerendia (finerenone). The filing seeks approval for treating adults with chronic kidney disease (CKD) who do not have diabetes, building on its existing approvals for CKD associated with Type 1 and Type 2 diabetes. This move follows positive results from the Phase III FIND-CKD trial, which showed a significant reduction in kidney disease progression.
In the United Kingdom, Foreign Secretary Ed Miliband announced a diplomatic shift regarding the British presence in Jerusalem. Following talks with Israeli officials, the UK Consulate General in East Jerusalem will remain open but will be renamed the "UK Mission, Jerusalem." Miliband emphasized that the UK would refrain from reciprocal diplomatic action as long as discussions remain "credible," even as the government works to rebuild its staff presence in the region following recent security-related withdrawals.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.